1. Home
  2. MOVE vs REVB Comparison

MOVE vs REVB Comparison

Compare MOVE & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOVE
  • REVB
  • Stock Information
  • Founded
  • MOVE 2018
  • REVB 2020
  • Country
  • MOVE United States
  • REVB United States
  • Employees
  • MOVE N/A
  • REVB N/A
  • Industry
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOVE Health Care
  • REVB Health Care
  • Exchange
  • MOVE Nasdaq
  • REVB Nasdaq
  • Market Cap
  • MOVE 4.5M
  • REVB 3.8M
  • IPO Year
  • MOVE 2021
  • REVB N/A
  • Fundamental
  • Price
  • MOVE $0.58
  • REVB $2.58
  • Analyst Decision
  • MOVE Buy
  • REVB
  • Analyst Count
  • MOVE 1
  • REVB 0
  • Target Price
  • MOVE $30.00
  • REVB N/A
  • AVG Volume (30 Days)
  • MOVE 67.1K
  • REVB 164.5K
  • Earning Date
  • MOVE 08-26-2025
  • REVB 08-08-2025
  • Dividend Yield
  • MOVE N/A
  • REVB N/A
  • EPS Growth
  • MOVE N/A
  • REVB N/A
  • EPS
  • MOVE N/A
  • REVB N/A
  • Revenue
  • MOVE $1,013,000.00
  • REVB N/A
  • Revenue This Year
  • MOVE $1,460.71
  • REVB N/A
  • Revenue Next Year
  • MOVE $96.77
  • REVB N/A
  • P/E Ratio
  • MOVE N/A
  • REVB N/A
  • Revenue Growth
  • MOVE N/A
  • REVB N/A
  • 52 Week Low
  • MOVE $0.51
  • REVB $2.11
  • 52 Week High
  • MOVE $6.97
  • REVB $168.00
  • Technical
  • Relative Strength Index (RSI)
  • MOVE 40.34
  • REVB 45.75
  • Support Level
  • MOVE $0.56
  • REVB $2.39
  • Resistance Level
  • MOVE $0.63
  • REVB $2.70
  • Average True Range (ATR)
  • MOVE 0.06
  • REVB 0.21
  • MACD
  • MOVE -0.01
  • REVB 0.03
  • Stochastic Oscillator
  • MOVE 15.20
  • REVB 51.61

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: